Abstract:Highlights • Flavonoids have been considered as a potent anti-fibrotic candidate. • The limitations of flavonoids decrease its therapeutic efficacy. • Flavonoids-based nanomedicine aids in sustained drug release, targeted drug delivery, and improves drug efficiency. • Flavonoids-based hepatic stellate cells targeted nanomedicine ensures efficient anti-fibrotic effect. Liver fibrosis remains a life-threatening pathological condition, which might lead to complications like cirrhosis and hepatocellular carcinoma when left untreated. The lack of definitive anti-fibrotic drugs and the possible complications of the clinically available drug compounds have paved the way for flavonoids-based liver fibrosis treatment. However, the limitations of flavonoids in biological systems, such as poor water solubility, low biocompatibility, rapid degradation, decreased half-life, and untargeted action, have been addressed previously by conjugating flavonoids with nanoparticles. This review summarizes the flavonoids-based nanomedicines tested against liver fibrosis, their characteristic significance, and the mechanism of action. Further, it provides insight into an effective anti-fibrotic therapy. Flavonoids-based nanomedicines such as silymarin-loaded gold nanoparticles, silymarin-chitosan nanoparticles, polyethylene Sebacate-silymarin nanomaterials, silymarin-Eudragit® RS100, silibinin-embedded polyethyleneimine-oleic acid, naringenin solid lipid nanomedicines, quercetin nanoliposomes and nanocapsules, galangin-Eudragit® RS100 nano formulation, and baicalin nanoliposomes synthesized at controlled size, charge, and shape with surface modifications have proven to be effective against liver fibrosis. These flavonoids-based nanomedicines overcome the limitations of conventionally administered flavonoids and facilitate their effective exertion of target-specific anti-inflammatory, antioxidant, and anti-fibrotic activities. However, among the widely available flavonoids, only a very few have been studied as nanomedicines against liver fibrosis. Therefore, exploring different combinations of flavonoids with nanomaterials, addressing the limitations of flavonoids-based nanomedicines, and translating into clinical trials could shed a light on a promising anti-fibrotic treatment strategy. Graphical abstract Download : Download high-res image (347KB) Download : Download full-size image

Naringenin Loaded Multifunctional Nanoparticles to Enhance the Chemotherapeutic Efficacy in Hepatic Fibrosis.

Study on the Inhibitory Effects of Naringenin-Loaded Nanostructured Lipid Carriers Against Nonalcoholic Fatty Liver Disease.

Nanoliposome Improves Inhibitory Effects of Naringenin on Nonalcoholic Fatty Liver Disease in Mice

Enhanced Solubility and Bioavailability of Naringenin Via Liposomal Nanoformulation: Preparation and in Vitro and in Vivo Evaluations

Beneficial effects of naringenin in liver diseases: Molecular mechanisms

Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles

Naringenin Nano-Delivery Systems and Their Therapeutic Applications

Formulation and Intestinal Absorption of Naringenin Loaded Nanostructured Lipid Carrier and Its Inhibitory Effects on Nonalcoholic Fatty Liver Disease.

Evaluation of the hepatoprotective effect of naringenin loaded nanoparticles against acetaminophen overdose toxicity

Naringenin Alleviates Liver FIbrosis by Triggering Autophagy-Dependent Ferroptosis in Hepatic Stellate Cells

Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress

Naringenin enhances the efficacy of ferroptosis inducers by attenuating aerobic glycolysis by activating the AMPK-PGC1α signalling axis in liver cancer

Empowering Naringin's Anti-Inflammatory Effects through Nanoencapsulation

Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis

Encapsulation of Hydrophobic and Low-Soluble Polyphenols into Nanoliposomes by pH-Driven Method: Naringenin and Naringin as Model Compounds

Naringin-loaded Polymeric Micelles As Buccal Tablets: Formulation, Characterization, in Vitro Release, Cytotoxicity and Histopathology Studies

Fabrication of ibuprofen/naringenin-coloaded into zein/sodium caseinate nanoparticles: evaluation of antiproliferative activity and apoptosis induction in liver cancer cells

Biological Activities and Solubilization Methodologies of Naringin

Antifibrotic and Antioxidant Effects of a Tetrahedral Framework Nucleic Acid-Based Chlorogenic Acid Delivery System

Mannose 6-Phosphate-modified Bovine Serum Albumin Nanoparticles for Controlled and Targeted Delivery of Sodium Ferulate for Treatment of Hepatic Fibrosis.